医療食品市場調査レポート : 2030年までの予測

Report Overview

Medical Foods Market Research Report Forecast to 2030

Market Overview
Medical Foods Market is anticipated to register a CAGR of 6.3% during the review period. The rising power of consistent ailments, creating energizing needs among people, and uncovering issues about prebiotics and probiotic things are driving market advancement.
Consistent afflictions, for instance, cardiovascular, neurological, urological, and overpowering ailments are growing from one side of the planet to the other. Heart issues are ending up being more typical than other persevering contaminations in view of a shortfall of dynamic work, being overweight, lamentable food, or having a family parentage.
Diabetes is maybe the most notable persevering illness, and its recurrence is reliably growing. For instance, according to World Prosperity Affiliation (WHO) estimations conveyed in 2019, diabetes is responsible for by and large 1.5 million passings and is the tenth top justification for death. Additionally, rising income in medical foods to supervise and control diabetic neuropathy and diabetes is supposed to drive market headway.
Market Segmentation
Vitamins and minerals, proteins, omega-3 fatty acids, isoflavones, phytosterols, and other nutrients are included in the segmentation of the medical foods market based on nutritional ingredients. Based on the method of administration, the Medical Foods Market is divided into oral and enteral segments. Pills, powder, and other items are included in the segmentation of the Market based on Form.
Chronic renal disease, nutritional deficiencies, neurological and psychological disorders, metabolic disorders, pain management, gastrointestinal disorders, orphan illnesses, and others are among the applications used to segment the medical foods market. Based on a distribution channel that comprises retail pharmacies, hospital pharmacies, e-commerce, and others, the Market is segmented.
Regional Insights
The North American medical foods market represented the biggest market share in 2022. This is because of the rising pervasiveness of ongoing sicknesses like diabetes, disease, cardiovascular problems, and others, the ascent in the reception of medical foods in the region, and the rising key organization and expanding speculation by key part in the region.
Europe’s medical foods market represents the second-biggest market share because of the rising consciousness of the advantages of medical foods, the developing improvement of new details, for example, plant-based proteins and probiotics, and the rising maturing populace.
The Asia-Pacific medical foods market is supposed to develop a huge expansion because of the further developing medical care framework, rising geriatric populace and illnesses related to advanced age, and developing well-being mindfulness among the populace in the Asia-Pacific region.
The remainder of the World is sectioned into the Center East, Africa, and Latin America. The medical foods market in the previously mentioned regions is probably going to observe development because of further developing medical services offices, the developing accessibility of medical food items, and the rising predominance of constant illnesses like diabetes, malignant growth, and cardiovascular problems in these regions.
Major Players
Key Companies in the Medical Foods Market are Danone SA (France), Abbott (US), Fresenius Kabi AG (Germany), TARGETED MEDICAL PHARMA INC (US), Metagenics LLC (US), Nestlé (Switzerland), Reckitt Benckiser Group PLC (UK), Medtrition, Inc (US), Primus Pharmaceuticals, inc (US), and Alfasigma USA, Inc (US).

Table of Contents

1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.4 FORECASTING TECHNIQUES
3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.5.1 BOTTOM-UP APPROACH
3.5.2 TOP-DOWN APPROACH
3.6 DATA TRIANGULATION
3.7 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 GROWING NUTRITIONAL DEFICIENCY AMONG PEOPLE
4.2.3 RAISING AWARENESS ABOUT PREBIOTICS AND PROBIOTIC PRODUCTS
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS REGARDING MEDICAL FOOD
4.4 OPPORTUNITIES
4.4.1 INCREASING PRODUCT LAUNCH INITIATIVES AND CONSTANT INNOVATIONS IN DEVELOPING PRODUCTS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL FOODS MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 IMPACT ON MARKET PLAYERS
6 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS
6.1 OVERVIEW
6.2 VITAMINS AND MINERALS
6.3 PROTEINS
6.4 OMEGA-3
6.5 ISOFLAVONES
6.6 PHYTOSTEROLS
6.7 OTHERS
7 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION
7.1 OVERVIEW
7.2 ORAL
7.3 ENTERAL
8 GLOBAL MEDICAL FOODS MARKET, BY FORM
8.1 OVERVIEW
8.2 PILLS
8.3 POWDER
8.4 OTHERS
9 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CHRONIC KIDNEY DISEASE
9.3 NUTRITIONAL DEFICIENCY
9.4 NEUROLOGICAL & PSYCHOLOGICAL DISORDERS
9.5 METABOLIC DISORDERS
9.6 PAIN MANAGEMENT
9.7 GASTROINTESTINAL DISORDERS
9.8 ORPHAN DISEASES
9.9 OTHERS
10 GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 E-COMMERCE
10.3 HOSPITAL PHARMACIES
10.4 RETAIL PHARMACIES
10.5 OTHERS
11 MEDICAL FOODS MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 UK
11.3.3 FRANCE
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL FOODS MARKET
12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL FOODS MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
12.6.2 MERGER/ACQUISITION
12.6.3 EXPANSION/ INVESTMENT
12.7 MAJOR PLAYERS SALES ANALYSIS
12.8 MAJOR PLAYERS R&D ANALYSIS
13 COMPANY PROFILES
13.1 DANONE SA
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ABBOTT
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 FRESENIUS KABI AG
13.3.1 COMPANY OVERVIEW
13.3.2 PRODUCTS OFFERED
13.3.3 KEY DEVELOPMENTS
13.3.4 SWOT ANALYSIS
13.3.5 KEY STRATEGIES
13.4 TARGETED MEDICAL PHARMA INC
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 METAGENICS LLC
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 KEY STRATEGIES
13.6 NESTLÉ
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 RECKITT BENCKISER GROUP PLC
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 MEDTRITION, INC
13.8.1 COMPANY OVERVIEWS
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 KEY STRATEGIES
13.9 PRIMUS PHARMACEUTICALS, INC
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 KEY STRATEGIES
13.10 ALFASIGMA USA, INC
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS OFFERED
13.10.4 KEY DEVELOPMENTSS
13.10.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 3 GLOBAL MEDICAL FOODS MARKET, FOR VITAMINS AND MINERALS, BY REGION, 2019–2030 (USD BILLION)
TABLE 4 GLOBAL MEDICAL FOODS MARKET, FOR PROTEINS, BY REGION, 2019–2030 (USD BILLION)
TABLE 5 GLOBAL MEDICAL FOODS MARKET, FOR OMEGA-3, BY REGION, 2019–2030 (USD BILLION)
TABLE 6 GLOBAL MEDICAL FOODS MARKET, FOR ISOFLAVONES, BY REGION, 2019–2030 (USD BILLION)
TABLE 7 GLOBAL MEDICAL FOODS MARKET, FOR PHYTOSTEROLS, BY REGION, 2019–2030 (USD BILLION)
TABLE 8 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 9 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 10 GLOBAL MEDICAL FOODS MARKET, FOR ORAL, BY REGION, 2019–2030 (USD BILLION)
TABLE 11 GLOBAL MEDICAL FOODS MARKET, FOR ENTERAL, BY REGION, 2019–2030 (USD BILLION)
TABLE 12 GLOBAL MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 13 GLOBAL MEDICAL FOODS MARKET, FOR PILLS, BY REGION, 2019–2030 (USD BILLION)
TABLE 14 GLOBAL MEDICAL FOODS MARKET, FOR POWDER, BY REGION, 2019–2030 (USD BILLION)
TABLE 15 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 16 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 17 GLOBAL MEDICAL FOODS MARKET, FOR CHRONIC KIDNEY DISEASE, BY REGION, 2019–2030 (USD BILLION)
TABLE 18 GLOBAL MEDICAL FOODS MARKET, FOR NUTRITIONAL DEFICIENCY, BY REGION, 2019–2030 (USD BILLION)
TABLE 19 GLOBAL MEDICAL FOODS MARKET, FOR NEUROLOGICAL & PSYCHOLOGICAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 20 GLOBAL MEDICAL FOODS MARKET, FOR METABOLIC DISORDERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 21 GLOBAL MEDICAL FOODS MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019–2030 (USD BILLION)
TABLE 22 GLOBAL MEDICAL FOODS MARKET, FOR GASTROINTESTINAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 23 GLOBAL MEDICAL FOODS MARKET, FOR ORPHAN DISEASES, BY REGION, 2019–2030 (USD BILLION)
TABLE 24 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 25 GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 26 GLOBAL MEDICAL FOODS MARKET, FOR E-COMMERCE, BY REGION, 2019–2030 (USD BILLION)
TABLE 27 GLOBAL MEDICAL FOODS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)
TABLE 28 GLOBAL MEDICAL FOODS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)
TABLE 29 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)
TABLE 30 GLOBAL: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
TABLE 31 NORTH AMERICA: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)
TABLE 32 NORTH AMERICA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 33 NORTH AMERICA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 34 NORTH AMERICA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 35 NORTH AMERICA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 36 NORTH AMERICA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 37 US: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 38 US: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 39 US: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 40 US: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 41 US: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 42 CANADA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 43 CANADA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 44 CANADA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 45 CANADA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 46 CANADA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 47 EUROPE: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
TABLE 48 EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 49 EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 50 EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 51 EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 52 EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 53 GERMANY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 54 GERMANY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 55 GERMANY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 56 GERMANY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 57 GERMANY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 58 UK: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 59 UK: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 60 UK: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 61 UK: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 62 UK: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 63 FRANCE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 64 FRANCE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 65 FRANCE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 66 FRANCE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 67 FRANCE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 68 ITALY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 69 ITALY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 70 ITALY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 71 ITALY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 72 ITALY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 73 SPAIN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 74 SPAIN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 75 SPAIN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 76 SPAIN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 77 SPAIN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 78 REST OF EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 79 REST OF EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 80 REST OF EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 81 REST OF EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 82 REST OF EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 83 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)
TABLE 84 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 85 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 86 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 87 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 88 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 89 JAPAN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 90 JAPAN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 91 JAPAN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 92 JAPAN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 93 JAPAN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 94 CHINA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 95 CHINA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 96 CHINA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 97 CHINA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 98 CHINA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 99 INDIA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 100 INDIA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 101 INDIA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 102 INDIA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 103 INDIA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 104 SOUTH KOREA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 105 SOUTH KOREA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 106 SOUTH KOREA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 107 SOUTH KOREA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 108 SOUTH KOREA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 109 AUSTRALIA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 110 AUSTRALIA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 111 AUSTRALIA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 112 AUSTRALIA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 113 AUSTRALIA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 114 REST OF ASIA-PACIFIC: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 115 REST OF ASIA-PACIFIC: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 116 REST OF ASIA-PACIFIC: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 117 REST OF ASIA-PACIFIC: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 118 REST OF ASIA-PACIFIC: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 119 REST OF THE WORLD: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
TABLE 120 REST OF THE WORLD: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 121 REST OF THE WORLD: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 122 REST OF THE WORLD: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 123 REST OF THE WORLD: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 124 REST OF THE WORLD: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 125 MIDDLE EAST: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 126 MIDDLE EAST: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 127 MIDDLE EAST: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 128 MIDDLE EAST: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 129 MIDDLE EAST: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 130 AFRICA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 131 AFRICA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 132 AFRICA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 133 AFRICA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 134 AFRICA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 135 LATIN AMERICA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)
TABLE 136 LATIN AMERICA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)
TABLE 137 LATIN AMERICA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)
TABLE 138 LATIN AMERICA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 139 LATIN AMERICA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)
TABLE 140 MAJOR PLAYERS IN THE GLOBAL MEDICAL FOODS MARKET
TABLE 141 MOST ACTIVE PLAYER IN THE GLOBAL MEDICAL FOODS MARKET
TABLE 142 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 143 MERGER/ACQUISITION
TABLE 144 EXPANSION/ INVESTMENT
TABLE 145 DANONE PRODUCTS OFFERED
TABLE 146 DANONE: KEY DEVELOPMENTS
TABLE 147 ABBOTT: PRODUCTS OFFERED
TABLE 148 ABBOTT: KEY DEVELOPMENTS
TABLE 149 FRESENIUS KABI AG: PRODUCTS OFFERED
TABLE 150 FRESENIUS KABI AG: KEY DEVELOPMENTS
TABLE 151 MEDICAL FOODS: PRODUCTS OFFERED
TABLE 152 METAGENICS LLC: PRODUCTS OFFERED
TABLE 153 NESTLÉ: PRODUCTS OFFERED
TABLE 154 NESTLÉ: KEY DEVELOPMENTS
TABLE 155 RECKITT BENCKISER GROUP PLC: PRODUCTS OFFERED
TABLE 156 MEDTRITION INC: PRODUCTS OFFERED
TABLE 157 PRIMUS PHARMACEUTICALS, INC: PRODUCTS OFFERED
TABLE 158 ALFASIGMA USA, INC: PRODUCTS OFFERED

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL MEDICAL FOODS MARKET STRUCTURE
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL MEDICAL FOODS MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL MEDICAL FOODS MARKET
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MEDICAL FOODS MARKET
FIGURE 9 GLOBAL MEDICAL FOODS MARKET, NUTRITIONAL INGREDIENTS SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 10 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2022 & 2030 (USD BILLION)
FIGURE 11 GLOBAL MEDICAL FOODS MARKET SHARE (%), BY NUTRITIONAL INGREDIENTS, 2022
FIGURE 12 GLOBAL MEDICAL FOODS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 13 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2022 & 2030 (USD BILLION)
FIGURE 14 GLOBAL MEDICAL FOODS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION, 2022
FIGURE 15 GLOBAL MEDICAL FOODS MARKET, FORM SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 16 GLOBAL MEDICAL FOODS MARKET, BY FORM, 2022 & 2030 (USD BILLION)
FIGURE 17 GLOBAL MEDICAL FOODS MARKET SHARE (%), BY FORM, 2022
FIGURE 18 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)
FIGURE 19 GLOBAL MEDICAL FOODS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 20 GLOBAL MEDICAL FOODS MARKET SHARE (%), BY APPLICATION, 2022
FIGURE 21 GLOBAL MEDICAL FOODS MARKET, DISTRIBUTION CHANNEL SEGMENT ATTRACTIVENESS, (USD BILLION)
FIGURE 22 GLOBAL MEDICAL FOODS MARKET, BY END USER, 2022 & 2030 (USD BILLION)
FIGURE 23 GLOBAL MEDICAL FOODS MARKET SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 24 GLOBAL: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)
FIGURE 25 GLOBAL: MEDICAL FOODS MARKET SHARE (%), BY REGION, 2022
FIGURE 26 NORTH AMERICA MARKET ANALYSIS: MEDICAL FOODS MARKET, 2019–2030 (USD BILLION)
FIGURE 27 NORTH AMERICA: MEDICAL FOODS MARKET, BY REGION, 2022-2030 (USD BILLION)
FIGURE 28 NORTH AMERICA: MEDICAL FOODS MARKET SHARE (%), BY REGION 2022
FIGURE 29 EUROPE MARKET ANALYSIS: MEDICAL FOODS MARKET, 2019–2030 (USD BILLION)
FIGURE 30 EUROPE: MEDICAL FOODS MARKET, BY REGION, 2022-2030 (USD BILLION)
FIGURE 31 EUROPE: MEDICAL FOODS MARKET SHARE (%), BY REGION 2022
FIGURE 32 ASIA-PACIFIC MARKET ANALYSIS: MEDICAL FOODS MARKET, 2019–2030 (USD BILLION)
FIGURE 33 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY COUNTRY, 2022-2030 (USD BILLION)
FIGURE 34 ASIA-PACIFIC: MEDICAL FOODS MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 35 REST OF THE WORLD MARKET ANALYSIS: MEDICAL FOODS MARKET, 2022–2030 (USD BILLION)
FIGURE 36 REST OF THE WORLD: MEDICAL FOODS MARKET, BY REGION, 2022-2030 (USD BILLION)
FIGURE 37 REST OF THE WORLD: MEDICAL FOODS MARKET SHARE (%), BY REGION, 2022
FIGURE 38 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 39 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MEDICAL FOODS MARKET
FIGURE 40 GLOBAL MEDICAL FOODS MARKET: COMPETITIVE LANDSCAPE
FIGURE 41 MAJOR PLAYERS SALES, 2022
FIGURE 42 MAJOR PLAYER R&D EXPENDITURE, 2022
FIGURE 43 DANONE SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 DANONE: SWOT ANALYSIS
FIGURE 45 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 ABBOTT: SWOT ANALYSIS
FIGURE 47 FRESENIUS KABI AG: FINANCIAL OVERVIEW
FIGURE 48 FRESENIUS KABI AG: SWOT ANALYSIS
FIGURE 49 NESTLÉ: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 50 NESTLÉ: SWOT ANALYSIS
FIGURE 51 RECKITT BENCKISER GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 52 RECKITT BENCKISER GROUP PLC: SWOT ANALYSIS